TY - JOUR AU - Lloyd-Jones, D. M. PY - 2010 DA - 2010// TI - Cardiovascular risk prediction: basic concepts, current status, and future directions JO - Circulation VL - 121 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.849166 DO - 10.1161/CIRCULATIONAHA.109.849166 ID - Lloyd-Jones2010 ER - TY - JOUR AU - Heidenreich, P. A. AU - Trogdon, J. G. AU - Khavjou, O. A. AU - Butler, J. AU - Dracup, K. AU - Ezekowitz, M. D. AU - Finkelstein, E. A. AU - Hong, Y. AU - Johnston, S. C. AU - Khera, A. AU - Lloyd-Jones, D. M. AU - Nelson, S. A. AU - Nichol, G. AU - Orenstein, D. AU - Wilson, P. W. AU - Woo, Y. J. PY - 2011 DA - 2011// TI - Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIR.0b013e31820a55f5 DO - 10.1161/CIR.0b013e31820a55f5 ID - Heidenreich2011 ER - TY - JOUR AU - Ross, R. PY - 1999 DA - 1999// TI - Atherosclerosis–an inflammatory disease JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199901143400207 DO - 10.1056/NEJM199901143400207 ID - Ross1999 ER - TY - JOUR AU - Madjid, M. AU - Willerson, J. T. PY - 2011 DA - 2011// TI - Inflammatory markers in coronary heart disease JO - Br Med Bull VL - 100 UR - https://doi.org/10.1093/bmb/ldr043 DO - 10.1093/bmb/ldr043 ID - Madjid2011 ER - TY - JOUR AU - Ikonomidis, I. AU - Michalakeas, C. A. AU - Lekakis, J. AU - Parissis, J. AU - Anastasiou-Nana, M. PY - 2011 DA - 2011// TI - The role of lipoprotein-associated phospholipase A2 (Lp-PLA(2)) in cardiovascular disease JO - Rev Recent Clin Trials VL - 6 UR - https://doi.org/10.2174/157488711795177903 DO - 10.2174/157488711795177903 ID - Ikonomidis2011 ER - TY - JOUR AU - Cai, A. AU - Zheng, D. AU - Qiu, R. AU - Mai, W. AU - Zhou, Y. PY - 2013 DA - 2013// TI - Lipoprotein-associated phospholipase A2 (Lp-PLA(2)): a novel and promising biomarker for cardiovascular risks assessment JO - Dis Markers VL - 34 UR - https://doi.org/10.1155/2013/432136 DO - 10.1155/2013/432136 ID - Cai2013 ER - TY - JOUR AU - Theilmeier, G. AU - De Geest, B. AU - Van Veldhoven, P. P. AU - Stengel, D. AU - Michiels, C. AU - Lox, M. AU - Landeloos, M. AU - Chapman, M. J. AU - Ninio, E. AU - Collen, D. AU - Himpens, B. AU - Holvoet, P. PY - 2000 DA - 2000// TI - HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/-mice JO - FASEB J VL - 14 UR - https://doi.org/10.1096/fj.99-1029com DO - 10.1096/fj.99-1029com ID - Theilmeier2000 ER - TY - JOUR AU - Wilensky, R. L. AU - Shi, Y. AU - Mohler, E. R. AU - Hamamdzic, D. AU - Burgert, M. E. AU - Li, J. AU - Postle, A. AU - Fenning, R. S. AU - Bollinger, J. G. AU - Hoffman, B. E. AU - Pelchovitz, D. J. AU - Yang, J. AU - Mirabile, R. C. AU - Webb, C. L. AU - Zhang, L. AU - Zhang, P. AU - Gelb, M. H. AU - Walker, M. C. AU - Zalewski, A. AU - Macphee, C. H. PY - 2008 DA - 2008// TI - Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1870 DO - 10.1038/nm.1870 ID - Wilensky2008 ER - TY - JOUR AU - May, H. T. AU - Horne, B. D. AU - Anderson, J. L. AU - Wolfert, R. L. AU - Muhlestein, J. B. AU - Renlund, D. G. AU - Clarke, J. L. AU - Kolek, M. J. AU - Bair, T. L. AU - Pearson, R. R. AU - Sudhir, K. AU - Carlquist, J. F. PY - 2006 DA - 2006// TI - Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death JO - Am Heart J VL - 152 UR - https://doi.org/10.1016/j.ahj.2006.01.011 DO - 10.1016/j.ahj.2006.01.011 ID - May2006 ER - TY - JOUR AU - Jenny, N. S. AU - Solomon, C. AU - Cushman, M. AU - Tracy, R. P. AU - Nelson, J. J. AU - Psaty, B. M. AU - Furberg, C. D. PY - 2010 DA - 2010// TI - Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study JO - Atherosclerosis VL - 209 UR - https://doi.org/10.1016/j.atherosclerosis.2009.09.021 DO - 10.1016/j.atherosclerosis.2009.09.021 ID - Jenny2010 ER - TY - JOUR AU - Thompson, A. AU - Gao, P. AU - Orfei, L. AU - Watson, S. AU - Di, A. E. AU - Kaptoge, S. AU - Ballantyne, C. AU - Cannon, C. P. AU - Criqui, M. AU - Cushman, M. AU - Hofman, A. AU - Packard, C. AU - Thompson, S. G. AU - Collins, R. AU - Danesh, J. PY - 2010 DA - 2010// TI - Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60319-4 DO - 10.1016/S0140-6736(10)60319-4 ID - Thompson2010 ER - TY - JOUR AU - Dohi, T. AU - Miyauchi, K. AU - Okazaki, S. AU - Yokoyama, T. AU - Ohkawa, R. AU - Nakamura, K. AU - Yanagisawa, N. AU - Tsuboi, S. AU - Ogita, M. AU - Yokoyama, K. AU - Kurata, T. AU - Yatomi, Y. AU - Daida, H. PY - 2011 DA - 2011// TI - Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome JO - Atherosclerosis VL - 219 UR - https://doi.org/10.1016/j.atherosclerosis.2011.09.019 DO - 10.1016/j.atherosclerosis.2011.09.019 ID - Dohi2011 ER - TY - JOUR AU - Anderson, J. L. PY - 2008 DA - 2008// TI - Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention JO - Am J Cardiol VL - 101 UR - https://doi.org/10.1016/j.amjcard.2008.04.015 DO - 10.1016/j.amjcard.2008.04.015 ID - Anderson2008 ER - TY - JOUR AU - Corson, M. A. AU - Jones, P. H. AU - Davidson, M. H. PY - 2008 DA - 2008// TI - Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker JO - Am J Cardiol VL - 101 UR - https://doi.org/10.1016/j.amjcard.2008.04.018 DO - 10.1016/j.amjcard.2008.04.018 ID - Corson2008 ER - TY - JOUR AU - Cannon, C. P. AU - Braunwald, E. AU - McCabe, C. H. AU - Rader, D. J. AU - Rouleau, J. L. AU - Belder, R. AU - Joyal, S. V. AU - Hill, K. A. AU - Pfeffer, M. A. AU - Skene, A. M. PY - 2004 DA - 2004// TI - Intensive versus moderate lipid lowering with statins after acute coronary syndromes JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa040583 DO - 10.1056/NEJMoa040583 ID - Cannon2004 ER - TY - JOUR AU - Pedersen, T. R. AU - Faergeman, O. AU - Kastelein, J. J. AU - Olsson, A. G. AU - Tikkanen, M. J. AU - Holme, I. AU - Larsen, M. L. AU - Bendiksen, F. S. AU - Lindahl, C. AU - Szarek, M. AU - Tsai, J. PY - 2005 DA - 2005// TI - High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial JO - JAMA VL - 294 UR - https://doi.org/10.1001/jama.294.19.2437 DO - 10.1001/jama.294.19.2437 ID - Pedersen2005 ER - TY - JOUR AU - Kamstrup, P. R. AU - Benn, M. AU - Tybjaerg-Hansen, A. AU - Nordestgaard, B. G. PY - 2008 DA - 2008// TI - Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study JO - Circulation VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.715698 DO - 10.1161/CIRCULATIONAHA.107.715698 ID - Kamstrup2008 ER - TY - JOUR AU - Davidson, M. H. AU - Corson, M. A. AU - Alberts, M. J. AU - Anderson, J. L. AU - Gorelick, P. B. AU - Jones, P. H. AU - Lerman, A. AU - McConnell, J. P. AU - Weintraub, H. S. PY - 2008 DA - 2008// TI - Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines JO - Am J Cardiol VL - 101 UR - https://doi.org/10.1016/j.amjcard.2008.04.019 DO - 10.1016/j.amjcard.2008.04.019 ID - Davidson2008 ER - TY - JOUR AU - Brilakis, E. S. AU - McConnell, J. P. AU - Lennon, R. J. AU - Elesber, A. A. AU - Meyer, J. G. AU - Berger, P. B. PY - 2005 DA - 2005// TI - Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up JO - Eur Heart J VL - 26 UR - https://doi.org/10.1093/eurheartj/ehi010 DO - 10.1093/eurheartj/ehi010 ID - Brilakis2005 ER - TY - JOUR AU - Kiechl, S. AU - Willeit, J. AU - Mayr, M. AU - Viehweider, B. AU - Oberhollenzer, M. AU - Kronenberg, F. AU - Wiedermann, C. J. AU - Oberthaler, S. AU - Xu, Q. AU - Witztum, J. L. AU - Tsimikas, S. PY - 2007 DA - 2007// TI - Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study JO - Arterioscler Thromb Vasc Biol VL - 27 UR - https://doi.org/10.1161/ATVBAHA.107.145805 DO - 10.1161/ATVBAHA.107.145805 ID - Kiechl2007 ER - TY - JOUR AU - Tanaka, A. AU - Imanishi, T. AU - Kitabata, H. AU - Kubo, T. AU - Takarada, S. AU - Tanimoto, T. AU - Kuroi, A. AU - Tsujioka, H. AU - Ikejima, H. AU - Komukai, K. AU - Kataiwa, H. AU - Okouchi, K. AU - Kashiwaghi, M. AU - Ishibashi, K. AU - Matsumoto, H. AU - Takemoto, K. AU - Nakamura, N. AU - Hirata, K. AU - Mizukoshi, M. AU - Akasaka, T. PY - 2009 DA - 2009// TI - Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study JO - Eur Heart J VL - 30 UR - https://doi.org/10.1093/eurheartj/ehp122 DO - 10.1093/eurheartj/ehp122 ID - Tanaka2009 ER - TY - JOUR AU - Mega, J. L. AU - Simon, T. AU - Collet, J. P. AU - Anderson, J. L. AU - Antman, E. M. AU - Bliden, K. AU - Cannon, C. P. AU - Danchin, N. AU - Giusti, B. AU - Gurbel, P. AU - Horne, B. D. AU - Hulot, J. S. AU - Kastrati, A. AU - Montalescot, G. AU - Neumann, F. J. AU - Shen, L. AU - Sibbing, D. AU - Steg, P. G. AU - Trenk, D. AU - Wiviott, S. D. AU - Sabatine, M. S. PY - 2010 DA - 2010// TI - Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1543 DO - 10.1001/jama.2010.1543 ID - Mega2010 ER - TY - JOUR AU - Sorajja, P. AU - Gersh, B. J. AU - Cox, D. A. AU - McLaughlin, M. G. AU - Zimetbaum, P. AU - Costantini, C. AU - Stuckey, T. AU - Tcheng, J. E. AU - Mehran, R. AU - Lansky, A. J. AU - Grines, C. L. AU - Stone, G. W. PY - 2010 DA - 2010// TI - Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2009.11.063 DO - 10.1016/j.jacc.2009.11.063 ID - Sorajja2010 ER - TY - JOUR AU - LaRosa, J. C. AU - Grundy, S. M. AU - Waters, D. D. AU - Shear, C. AU - Barter, P. AU - Fruchart, J. C. AU - Gotto, A. M. AU - Greten, H. AU - Kastelein, J. J. AU - Shepherd, J. AU - Wenger, N. K. PY - 2005 DA - 2005// TI - Intensive lipid lowering with atorvastatin in patients with stable coronary disease JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa050461 DO - 10.1056/NEJMoa050461 ID - LaRosa2005 ER - TY - JOUR AU - Breen, D. M. AU - Dolinsky, V. W. AU - Zhang, H. AU - Ghanim, H. AU - Guo, J. AU - Mroziewicz, M. AU - Tsiani, E. L. AU - Bendeck, M. P. AU - Dandona, P. AU - Dyck, J. R. AU - Heximer, S. P. AU - Giacca, A. PY - 2012 DA - 2012// TI - Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism JO - Atherosclerosis VL - 222 UR - https://doi.org/10.1016/j.atherosclerosis.2012.03.021 DO - 10.1016/j.atherosclerosis.2012.03.021 ID - Breen2012 ER - TY - JOUR AU - Park, S. J. AU - Kang, S. J. AU - Virmani, R. AU - Nakano, M. AU - Ueda, Y. PY - 2012 DA - 2012// TI - In-stent neoatherosclerosis: a final common pathway of late stent failure JO - J Am Coll Cardiol VL - 59 UR - https://doi.org/10.1016/j.jacc.2011.10.909 DO - 10.1016/j.jacc.2011.10.909 ID - Park2012 ER - TY - JOUR AU - Packard, C. J. PY - 2009 DA - 2009// TI - Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target JO - Curr Opin Cardiol VL - 24 UR - https://doi.org/10.1097/HCO.0b013e32832bcb22 DO - 10.1097/HCO.0b013e32832bcb22 ID - Packard2009 ER - TY - JOUR AU - Rosenson, R. S. PY - 2010 DA - 2010// TI - Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes JO - Curr Opin Lipidol VL - 21 UR - https://doi.org/10.1097/MOL.0b013e32833eb581 DO - 10.1097/MOL.0b013e32833eb581 ID - Rosenson2010 ER - TY - JOUR AU - Colley, K. J. AU - Wolfert, R. L. AU - Cobble, M. E. PY - 2011 DA - 2011// TI - Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk JO - EPMA J VL - 2 UR - https://doi.org/10.1007/s13167-011-0063-4 DO - 10.1007/s13167-011-0063-4 ID - Colley2011 ER - TY - STD TI - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106: 3143-3421. ID - ref30 ER - TY - JOUR AU - Moldoveanu, E. AU - Mut-Vitcu, B. AU - Tanaseanu, G. R. AU - Marta, D. S. AU - Manea, G. AU - Kosaka, T. AU - Vidulescu, C. AU - Tanaseanu, C. PY - 2008 DA - 2008// TI - Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase JO - Clin Biochem VL - 41 UR - https://doi.org/10.1016/j.clinbiochem.2008.09.109 DO - 10.1016/j.clinbiochem.2008.09.109 ID - Moldoveanu2008 ER - TY - JOUR AU - Boffa, M. B. AU - Marcovina, S. M. AU - Koschinsky, M. L. PY - 2004 DA - 2004// TI - Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models JO - Clin Biochem VL - 37 UR - https://doi.org/10.1016/j.clinbiochem.2003.12.007 DO - 10.1016/j.clinbiochem.2003.12.007 ID - Boffa2004 ER - TY - JOUR AU - Tsimikas, S. AU - Tsironis, L. D. AU - Tselepis, A. D. PY - 2007 DA - 2007// TI - New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease JO - Arterioscler Thromb Vasc Biol VL - 27 UR - https://doi.org/10.1161/01.ATV.0000280571.28102.d4 DO - 10.1161/01.ATV.0000280571.28102.d4 ID - Tsimikas2007 ER - TY - JOUR AU - Garg, P. K. AU - McClelland, R. L. AU - Jenny, N. S. AU - Criqui, M. AU - Liu, K. AU - Polak, J. F. AU - Jorgensen, N. W. AU - Cushman, M. PY - 2011 DA - 2011// TI - Association of lipoprotein-associated phospholipase A(2) and endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA) JO - Vasc Med VL - 16 UR - https://doi.org/10.1177/1358863X11411360 DO - 10.1177/1358863X11411360 ID - Garg2011 ER - TY - JOUR AU - Turunen, P. AU - Puhakka, H. AU - Rutanen, J. AU - Hiltunen, M. O. AU - Heikura, T. AU - Gruchala, M. AU - Yla-Herttuala, S. PY - 2005 DA - 2005// TI - Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta JO - Atherosclerosis VL - 179 UR - https://doi.org/10.1016/j.atherosclerosis.2004.10.025 DO - 10.1016/j.atherosclerosis.2004.10.025 ID - Turunen2005 ER - TY - JOUR AU - Detopoulou, P. AU - Nomikos, T. AU - Fragopoulou, E. AU - Chrysohoou, C. AU - Antonopoulou, S. PY - 2013 DA - 2013// TI - Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy JO - Curr Heart Fail Rep VL - 10 UR - https://doi.org/10.1007/s11897-013-0131-2 DO - 10.1007/s11897-013-0131-2 ID - Detopoulou2013 ER - TY - JOUR AU - Packard, C. J. AU - O'Reilly, D. S. AU - Caslake, M. J. AU - McMahon, A. D. AU - Ford, I. AU - Cooney, J. AU - Macphee, C. H. AU - Suckling, K. E. AU - Krishna, M. AU - Wilkinson, F. E. AU - Rumley, A. AU - Lowe, G. D. PY - 2000 DA - 2000// TI - Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200010193431603 DO - 10.1056/NEJM200010193431603 ID - Packard2000 ER - TY - JOUR AU - Blankenberg, S. AU - Stengel, D. AU - Rupprecht, H. J. AU - Bickel, C. AU - Meyer, J. AU - Cambien, F. AU - Tiret, L. AU - Ninio, E. PY - 2003 DA - 2003// TI - Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis JO - J Lipid Res VL - 44 UR - https://doi.org/10.1194/jlr.M300086-JLR200 DO - 10.1194/jlr.M300086-JLR200 ID - Blankenberg2003 ER - TY - JOUR AU - Garza, C. A. AU - Montori, V. M. AU - McConnell, J. P. AU - Somers, V. K. AU - Kullo, I. J. AU - Lopez-Jimenez, F. PY - 2007 DA - 2007// TI - Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review JO - Mayo Clin Proc VL - 82 UR - https://doi.org/10.1016/S0025-6196(11)60992-0 DO - 10.1016/S0025-6196(11)60992-0 ID - Garza2007 ER - TY - JOUR AU - Kougias, P. AU - Chai, H. AU - Lin, P. H. AU - Lumsden, A. B. AU - Yao, Q. AU - Chen, C. PY - 2006 DA - 2006// TI - Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis JO - Med Sci Monit VL - 12 ID - Kougias2006 ER - TY - JOUR AU - Takeda, R. AU - Suzuki, E. AU - Satonaka, H. AU - Oba, S. AU - Nishimatsu, H. AU - Omata, M. AU - Fujita, T. AU - Nagai, R. AU - Hirata, Y. PY - 2005 DA - 2005// TI - Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats JO - Circulation VL - 111 UR - https://doi.org/10.1161/01.CIR.0000158482.83179.DB DO - 10.1161/01.CIR.0000158482.83179.DB ID - Takeda2005 ER - TY - JOUR AU - Miao, C. Y. AU - Li, Z. Y. PY - 2012 DA - 2012// TI - The role of perivascular adipose tissue in vascular smooth muscle cell growth JO - Br J Pharmacol VL - 165 UR - https://doi.org/10.1111/j.1476-5381.2011.01404.x DO - 10.1111/j.1476-5381.2011.01404.x ID - Miao2012 ER - TY - JOUR AU - Detopoulou, P. AU - Nomikos, T. AU - Fragopoulou, E. AU - Panagiotakos, D. B. AU - Pitsavos, C. AU - Stefanadis, C. AU - Antonopoulou, S. PY - 2009 DA - 2009// TI - Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults JO - Lipids Health Dis VL - 8 UR - https://doi.org/10.1186/1476-511X-8-19 DO - 10.1186/1476-511X-8-19 ID - Detopoulou2009 ER - TY - JOUR AU - Segev, A. AU - Kassam, S. AU - Buller, C. E. AU - Lau, H. K. AU - Sparkes, J. D. AU - Connelly, P. W. AU - Seidelin, P. H. AU - Natarajan, M. K. AU - Cohen, E. A. AU - Strauss, B. H. PY - 2004 DA - 2004// TI - Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting JO - Eur Heart J VL - 25 UR - https://doi.org/10.1016/j.ehj.2004.04.027 DO - 10.1016/j.ehj.2004.04.027 ID - Segev2004 ER - TY - JOUR AU - Delhaye, C. AU - Sudre, A. AU - Lemesle, G. AU - Marechaux, S. AU - Broucqsault, D. AU - Hennache, B. AU - Bauters, C. AU - Lablanche, J. M. PY - 2009 DA - 2009// TI - Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention JO - Cardiovasc Revasc Med VL - 10 UR - https://doi.org/10.1016/j.carrev.2009.01.005 DO - 10.1016/j.carrev.2009.01.005 ID - Delhaye2009 ER - TY - JOUR AU - Ballantyne, C. M. AU - Nambi, V. PY - 2005 DA - 2005// TI - Markers of inflammation and their clinical significance JO - Atheroscler Suppl VL - 6 UR - https://doi.org/10.1016/j.atherosclerosissup.2005.02.005 DO - 10.1016/j.atherosclerosissup.2005.02.005 ID - Ballantyne2005 ER - TY - JOUR AU - Elkind, M. S. AU - Tai, W. AU - Coates, K. AU - Paik, M. C. AU - Sacco, R. L. PY - 2006 DA - 2006// TI - High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke JO - Arch Intern Med VL - 166 UR - https://doi.org/10.1001/archinte.166.19.2073 DO - 10.1001/archinte.166.19.2073 ID - Elkind2006 ER -